received conventional CRT with 5FU or capecitabine. All patients got MRI and endorectal ultrasound (ERUS) at baseline, after completing FOLFOX 3-months regimen and after finishing conventional CRT. Patients underwent either full-thickness local excision or
Search Results
Ahmed Abdalla, Amr Aref, Amer Alame, Mohamad Barawi, Danny Ma, and Zyad Kafri
Javaughn Corey R. Gray, Jongho Kim, Michael Digianvittorio, Nancy K. Feeley, Paul J. Scheel, Stanley S. Siegelman, Elliot K. Fishman, and Steven P. Rowe
/MEK-targeted inhibitors. 2 , 11 In a recent study of patients with ECD neurologic involvement, a combination of anatomic MRI and metabolic imaging with FDG-PET showed a high rate of objective response to targeted therapies such as vemurafenib. 12 This report presents a
Heather H. Cheng, Alexandra O. Sokolova, Edward M. Schaeffer, Eric J. Small, and Celestia S. Higano
rectal examination and prostate MRI (NCT03805919). If clinical trial participation is not available, annual PSA measurement for carriers of high-risk mutations should begin at age 40 years ( Figure 2 ). Men with PSA levels greater than the median age
Raymond Elsoueidi, Jessica Craig, Hesham Mourad, and Elie M. Richa
/L), a creatinine level of 1.9 mg/dL (range, 0.6-1.3 mg/dL), and a glomerular filtration rate (GFR) of 38 mL/min. Imaging studies, including magnetic resonance cholangiopancreatography and MRI of the liver, revealed a perihilar liver mass measuring 48.6 x
Michelle L. McDonald and J. Kellogg Parsons
least one prior negative biopsy. 51 , 55 MRI Increasing interest is being shown in the role of multiparametric MRI in prostate cancer diagnosis. Recent evidence suggests a benefit of MRI-targeted prostate biopsy compared with standard transrectal
Stephanie A. Morris, Dorothy Farrell, and Piotr Grodzinski
, targeted nanoparticles can provide molecular imaging functionality through site- or activity-specific localization. Iron oxide nanoparticles provide a sensitive, low-toxicity alternative to standard MRI contrast agents, such as injected gadolinium. 39
Eric T. Wong and Steven Brem
tracking . J Mag Reson Imaging 2005 ; 22 : 710 – 717 . 45. Wong ET Jackson EF Hess KR . Correlation between dynamic MRI and outcome in patients with malignant gliomas . Neurology 1998 ; 50 : 777 – 781 . 46. Roberts HC Roberts
Chongkai Wang and Marwan Fakih
CA19-9 tumor marker response during treatment. (B) CT image from PET/CT scan before trastuzumab + lapatinib (red arrow: liver lesion, 2.4 × 1.4 cm). (C) MRI scan after 8 cycles of trastuzumab + lapatinib (red arrow: the same lesion, 0.7 × 0.9 cm
Agda Karina Eterovic, Ossama M. Maher, Joya Chandra, Ken Chen, Jason Huse, and Wafik Zaky
at the anterior mediastinum, liver, bone marrow, skull, and third lumber vertebra. Brain MRI revealed disease in the right orbital fossa extending to the middle cranial fossa, with no intracranial or cerebellar disease. The patient underwent fine
Brian J. Williams, Daniel M.S. Raper, Erin Godbout, T. David Bourne, Daniel M. Prevedello, Amin B. Kassam, and Deric M. Park
imaging, because plain radiographs often fail to diagnose chordoma and CT and MRI often end at S2. 15 , 18 , 19 Invasion and compression of adjacent neurologic structures can result in myriad symptoms, including weakness, numbness, bowel and bladder